Myriad Genetics Inc (NASDAQ:MYGN)

26.30
Delayed Data
As of 4:00pm ET
 +0.31 / +1.19%
Today’s Change
22.07
Today|||52-Week Range
50.44
-9.53%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Capone Mark C
President & Chief Executive Officer
Sale9/25/201818,295$46.65$853.5K-43.62%
Capone Mark C
President & Chief Executive Officer
Sale9/30/201818,295$46.00$841.6K-41.08%
Capone Mark C
President & Chief Executive Officer
Sale9/17/201811,025$46.35$511.0K-43.26%
Capone Mark C
President & Chief Executive Officer
Sale9/30/20188,727$46.00$401.4K-41.08%
Riggsbee R Bryan
Chief Financial Officer
Sale9/25/20186,653$46.65$310.4K-43.62%
Ford Alec
President
Sale9/25/20186,653$46.65$310.4K-43.62%
Riggsbee R Bryan
Chief Financial Officer
Sale9/30/20186,653$46.00$306.0K-41.08%
Ford Alec
President
Sale9/30/20186,653$46.00$306.0K-41.08%
Lanchbury Jerry S
Chief Scientific Officer
Sale9/17/20186,515$46.35$302.0K-43.26%
Marsh Richard M
Executive Vice President & General Counsel
Sale9/17/20186,314$46.35$292.7K-43.26%
Page of 6